Wordt geladen...
New strategies for applying targeted therapies to adrenocortical carcinoma
Adrenocortical carcinoma (ACC) is a rare, aggressive, and frequently deadly cancer. Up to 75% of all patients will eventually develop metastatic disease, and our current medical therapies for ACC provide limited – if any – survival benefit. These statistics highlight a crucial need for novel approac...
Bewaard in:
| Gepubliceerd in: | Curr Opin Endocr Metab Res |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7133705/ https://ncbi.nlm.nih.gov/pubmed/32258822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coemr.2019.07.006 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|